VS Health Corporation (NYSE: CVS) reported second-quarter 2021 earnings results today.
Total revenues increased 11.1% to $72.6 billion compared to the same period last year, driven by growth across all segments.
Net income attributable to CVS was $2.78 billion, or $2.10 per share, compared to $2.98 billion, or $2.26 per share, in the year-ago period. Adjusted EPS amounted to $2.42.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
